Depression and apathy in Parkinson's disease

Current Neurology and Neuroscience Reports

Volumn 7, Issue 4, 2007, Pages 295-301

  Richard, Irene Hegeman ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; NORADRENALIN; PAROXETINE; PLACEBO; PRAMIPEXOLE; RIVASTIGMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

APATHY; BECK DEPRESSION INVENTORY; BRAIN DEPTH STIMULATION; CARDIOTOXICITY; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; EMOTIONAL DISORDER; GENETIC VARIABILITY; HAMILTON SCALE; HUMAN; LOW DRUG DOSE; MEDICAL RECORD REVIEW; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROPATHOLOGY; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PHENOMENOLOGY; REVIEW; RISK FACTOR; TRANSCRANIAL MAGNETIC STIMULATION; URINE RETENTION;

ANTIDEPRESSIVE AGENTS; DEEP BRAIN STIMULATION; DEPRESSIVE DISORDER; HUMANS; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 34547116881     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-007-0045-z     Document Type: Review

References (39)

1. Schrag A: Quality of life and depression in Parkinson's disease. J Neurological Sci 2006, 248:151-157.
2. Schrag A, Hovris A, Morley D, et al.: Caregiver-burden in Parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Related Disord 2006, 12:35-41.
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC; 1994.
4. Marsh L, McDonald WM, Cummings J, et al.: Provisional diagnostic criteria for depression in Parkinson's disease: Report of a NINDS/NIMH Work Group. Mov Disord 2006, 21:148-158.
5. Miyasaki JM, Shannon K, Voon V, et al.: Practice parameter. evaluation and treatment of depression, psychosis, and dementia in Parkinson's disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006, 66:996-1002.
6. Mondolo F, Jahanshahi M, Grana A, et al.: The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease. Bebav Neurol 2006, 17:109-115.
7. McDonald WM, Holtzheimer PE, Haber M, et al.: Validity 0of the 30-item Geriatric Depression Scale in patients with Parkinson's disease. Mov Disord2006, 21:1618-1622.
8. Visser M, Leentjens AF, Marinus J, et al.: Reliability and validity of the Beck Depression Inventory in patients with Parkinson's disease. Mov Disord 2006, 21:668-672.
9. Ishihara L, Brayne C: A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurologica Scandinavica 2006, 113:211-220.
10. Barbas NR: Cognitive, affective, and psychiatric features of Parkinson's disease. Clin Geriatr Med 2006, 22:773-796.
11. Burn DJ, Tiangyou W, Allcock LM, et al.: Allelic variation of a functional polymorphism in the serotonin transporter gene and depression in Parkinson's disease. Parkinsonism Related Disord 2006, 12:139-141.
12. Menza MA, Palermo B, DiPaola R, et al.: Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter. J Geriatr Psychiatry Neurol 1999, 12:49-52.
13. Mössner R, Henneberg A, Schmitt A, et al.: Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease. Mol Psychiatry 2001, 6: 35O-352.
14. Richard IH, Kurlan R: The under-recognition of depression in Parkinson's disease. Neuropsychiatric Dis Treat 2006, 2:349-353.
15. Kuopio A, Marttila R, Hellenius H, et al.: The quality of life in Parkinson's disease. Mov Disord 2000, 15:216-223.
16. Shulman LM, Taback RL, Rabinstein AA, et al.: Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Related Disord 2002, 8:193-197.
17. Schiffer RB, Kurlan R, Rubin A: Evidence for atypical depression in Parkinson's disease. Am J Psychiatry 1988, 145:1020-1022.
18. Cummings J: Depression and Parkinson's disease. A review. Am J Psychiatry 1992, 149:443-454.
19. Ehrt UL, Bronnick K, Leentjens AF, et al.: Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease. Int J Geriatr Psychiatry 2006, 21:252-258.
20. Richard IH: Cognitive impairment in depression. In Secondary Dementias. Edited by Kurlan R. New York: Marcel Dekker; 2006:325-343.
21. Costa A, Peppe A, Carlesimo GA, et al.: Major and minor depression in Parkinson's disease: a neuropsychological investigation. Eur J Neurol 2006, 13:972-980.
22. Lieberman A: Are dementia and depression in Parkinson's disease related? J Neurological Sci 2006, 248:138-142.
23. Nelson J, Kennedy J, Pollock B, et al.: Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry 1999, 156:1024-1028.
24. Yeragani VK, Roose S, Mallavarapu M, et al.: Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. Neuropsychobiol 2002, 46:125-135.
25. Yeragani VK, Pesce V, Jayaraman A, et al.: Major depression with ischemic heart disease: Effects of paroxetine and nortriptyline on long-term heart rate variability measures. Biol Psychiatry2002, 52:418-429.
26. Antonini A, Tesei S, Zecchinelli A, et al.: Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: Effect on quality of life. Mov Disord 2006, 21:1119-1122.
27. Lemke MR, Brecht HM, Koester J, et al.: Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease. J Neurological Sci 2006, 248:266-270.
28. Barone P, Scarzella L, Marconi R, et al.: Pramipexole versus sertraline in the treatment of depression in Parkinson's disease. J Neurol 2006, 253:601-607.
29. Fregni F, Ono CR, Santos CM, et al.: Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD. Neurology 2006, 66:1629-1637.
30. Kirsch Darrow L, Fernandez HF, Marsiske M, et al.: Dissociating apathy and depression in Parkinson's disease. Neurology 2006 67:33-38.
31. Richard IH: Apathy does not equal depression in Parkinson disease: Why we should care? [editorial]. Neurology 2006, 67:10-11.
32. Bowers D, Miller K, Mikos A, et al.: Startling facts about emotion in Parkinson's disease: Blunted reactivity to aversive stimuli. Brain 2006, 129:3356-3365.
33. Aarsland D, Brønnick K, Ehrt U, et al.: Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. J Neurol Neurosurg Psychiatry 2007, 78:36-42.
34. Marin RS, Biedrzycki RC, Firinciogullari S: Reliability and validity of the apathy evaluation scale. Psychiatry Res 1991, 38:143-162.
35. Sockeel P, Dujardin K, Devos D, et al.: The Lille apathy rating scale (LAPS), a new instrument for detecting and qualifying apathy. validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006, 77:579-584.
36. Drapier D, Drapier S, Sauleau P, et al.: Does subthalamic nucleus stimulation induce apathy in Parkinson's disease? J Neurol 2006, 253:1083-1091.
37. Castelli L, Perozzo P, Zibetti M, et al.: Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits. Eur Neurol 2006, 55:136-144.
38. Voon V, Kubu C, Krack P, et al.: Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006, 21:S305-S327.
39. Dueschl G, Schade-Brittinger C, Krack P, et al.: A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006, 355:896-908.